Pharmaceutical company to pay $1 million to settle claims on switching drugs

Share this article:

The Maine subsidiary of Omnicare Pharmacy, a Fortune 500 company, agreed to pay $1 million to settle claims that it switched nursing home patients' prescriptions to a medication that would be more profitable for the company.

Omnicare provides medication for about 7,000 nursing home patients in Maine. The company is accused of creating fake prescriptions to switch patients' heartburn medicine, which meant that the state's Medicaid program paid $82 per month per patient instead of $15.

Patients were switched from tablet form of ranitidine, a generic heartburn medication, to the capsule form. Experts say the two different forms are not therapeutically equivalent.

The company denies the claims but said it settled the charges to avoid extraneous litigation costs.

Share this article:

More in News

Bill addressing admission status receives praise

A bill that would require hospitals to give patients a formal notice of their admission status has received strong support from healthcare associations.

Increased 'bed taxes' on nursing facilities warrant stricter federal oversight, report states

States have been increasingly taxing skilled nursing facilities and other healthcare providers to fund Medicaid in recent years, and federal authorities should look more closely at this trend, according to a government report released Tuesday.

Last chance: Tech Awards deadline arrives

Last chance: Tech Awards deadline arrives

There are hours left for innovative long-term care providers to enter the third annual McKnight's Excellence in Technology Awards. Submissions will be accepted until the stroke of midnight tonight.